Episurf Medical Ab Class B · OMXSTO:EPIS_B
Episurf Medical Ab Class B — Q1 2022 Earnings Presentation
8 slides from Episurf Medical Ab Class B's earnings presentation, Apr 29, 2022
Slide 1: Q1 2022 Presentation
Q1 2022 Presentation Stockholm, April 29th, 2022 Pål Ryfors, CEO episurf.com
Slide 2: COVID-19 remarks
COVID-19 remarks • As expected, 2022 started in a challenging way but improvements during late March
Slide 3: Q1 2022 results
Q1 2022 results • Highlights Q1 2022 ✓ Group net sales amounted to SEK 1.6m (1.6) ✓ Gross order intake amounted to SEK 1.7m (2.1) ✓ Loss for the period amounted to SEK -16.4m (-16.7) ✓ Product development and commercialisation in focus ✓ New record in number of customers (41, +25%) • Cash at the end
Slide 4: Q1 2022 Highlights
Q1 2022 Highlights • Commercial strategy ✓ Improved governance ✓ ICM (Indirect Channel Management) ✓ Market assessment ✓ Allocation of resources • EPIC knee trial ✓ Disappointment – full focus • Product development ✓ Episealer® Patellofemoral System – 510(k) application to Substantive review ✓ Epise
Slide 5: Creating a global commercial foundation – Update
Creating a global commercial foundation – Update H1 2022 H2 2022 ➔ Comment Hong Kong ! ✓ Progress on product registration India First surgeon meetings held Singapore ! ✓ Distributor appointed and regulatory filing under review Malaysia ! ✓ Regulatory clearance obtained Saudi Arabia ! ✓ Regulatory
Slide 6: Focus areas going forward
Focus areas going forward Market 2022 2023 2024 2025 opportunity Episealer® Knee Europe Increased commercial focus based ~USD 0.4bn & RoW on available data Patient Episealer® Knee US Patient follow-up PMA process ~USD 0.6bn recruitment Product launch and initial Episealer® Talus studies Episealer® T
Slide 7: Shareholders
Shareholders Shares (000s) % holding Shareholders, Mar 31, 2022 A B votes capital 1 Health Runner AB (Ilija Batljan) -- 34,771 13.0% 13.0% 2 Rhenman Partners -- 12,668 4.7% 4.8% 3 Fjärde AP-Fonden -- 12,537 4.7% 4.7% 4 Sebastian Jahreskog -- 11,089 4.1% 4.2% 5 Tredje AP-Fonden -- 9,980 3.7% 3.7% 6 L
Slide 8: Thank you!
Thank Q1 2022 Presentation you! Stockholm, April 29th, 2022 Pål Ryfors, CEO episurf.com